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Abstract
OBJECTIVE: To investigate the effects of Bazhen de-
coction (BZD), Siwu decoction (SWD) and Sijunzi
decoction (SJZD) in mice with anemia induced by
5-fluorouracil (5-FU) and discussed the possible
pharmacological hematopoietic mechanism to pro-
vide experimental evidence for the clinical use of
the three classical prescriptions in the treatment of
anemia.
METHODS: Anemia was induced by intravenous in-
jection of 5-FU and 80 female Kunming mice were
randomly, assigned to oral administration of SWD,
SJZD, or BZD daily for 10 days. Peripheral blood
cells count and bone marrow cell cycle were moni-
tored to evaluate anti-anemia effects. Serum cyto-
kines, interferon-γ (IFN-γ), interleukin-3 (IL-3), eryth-
ropoietin (EPO), granulocyte-macrophage colony
stimulating factor (GM-CSF), and tumor necrosis
factor-α (TNF-α) were assayed. EPO mRNA expres-
sion was assayed in kidney and liver tissue homoge-
nates.
RESULTS: BZD and SWD significantly increased the
number of red blood cells, hemoglobin concentra-
tion, and hematocrit, promoted bone marrow cells
to enter the cell cycle, proliferate and differentiate,
significantly increased IL-3 secretion, and signifi-
cantly inhibited IFN-γ secretion. BZD stimulated
transcription of EPO mRNA in the kidney and liver
and enhanced serum EPO expression. A therapeu-
tic effect of SJZD was not observed.
CONCLUSION: BZD and SWD treatment specifically
enhanced hematopoietic function and mediated
myelopoiesis by altering serum cytokines levels
and accelerating entry of bone marrow cells into
the cell cycle. Better curative effects were achieved
via nourishing both Qi and blood (BZD) than by en-
riching the blood (SWD) or invigorating Qi (SWZD)
alone.
Key words: Anemia; Blood-deficiency; Fluorouracil;
Bazhen decoction; Siwu decoction; Sijunzi decoc-
tion
INTRODUCTION
In Traditional Chinese Medicine (TCM), blood defi-
ciency is a syndrome with pathological changes such as
pale/sallow complexion, brittle nails, dizziness, palpita-
tion, numbness of the hands and feet, scanty and
light-colored menses, pale tongue and weak pulse.1 In
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TCM theory, blood deficiency is related to the intri-
cate balance of blood and Qi. In TCM, blood is the
red fluid circulating through the blood vessels and
nourishing the body tissues, a concept that corre-
sponds in part to that of modern Western Medicine.2
Qi is the invisible basic element or energy that makes
up the human body and supports vital activities of the
human body.2 In brief, insufficient blood generates
blood deficiency, subsequently resulting in Qi deficien-
cy, which in turn aggravates blood deficiency, ultimate-
ly forming a vicious circle.3
In recent decades, many practitioners of TMC have
come to regard blood deficiency as similar anemia as
defined in modern medicine. According to WHO crite-
ria, anemia is defined as a hemoglobin (Hb) concentra-
tion < 13 g/dL in men and < 12 g/dL in women.4-6 The
pathogenesis of anemia is multifactorial. For example,
hematopoietic damage caused by 5-FU can be im-
proved by prescription of blood tonics or drugs.7
TCM researchers develop animal models of blood defi-
ciency by methods including radiation exposure, chem-
ical agents, and immune modulation.8 Recent studies
of blood deficiency syndrome have utilized a mouse
model in which anemia is induced by 5-fluorouracil
(5-FU).7,9 5-FU is a antineoplastic, cell-cycle specific
drug that is widely used to treat a variety of tumors in-
cluding colorectal, breast and liver carcinomas. Follow-
ing administration, 5-FU is converted to fluorouracil
deoxynucleotide, which binds thymidine synthase,
leading to disruption of RNA, DNA, and protein bio-
synthesis. However, 5-FU usually suppresses the bone
marrow, and causes adverse gastrointestinal reactions
because nucleic acid metabolism in tumors is similar to
that in normal tissues.10,11 5-FU administration at a
dose of 150 mg/kg is known to result in long-term le-
sions of erythropoiesis and erythropoietin (EPO) pro-
duction in which mature erythroid cells (reticulocytes,
erythrocytes) and erythropoietic precursors (erythroid
colony-forming units, erythroid burst-forming units)
in the bone marrow were severely reduced.12
TCM is an excellent example of alternative and com-
plementary medicine with a long history, unique the-
ory system, and a variety of herbal remedies.13 In
TCM, enriching blood and balancing Qi and blood
are the basic therapies for blood deficiency. Siwu de-
coction (SWD), Sijunzi decoction (SJZD), and Ba-
zhen decoction (BZD), have been used in TCM clini-
cal practice to treat blood deficiency, Qi deficiency
and blood- and-Qi deficiency, respectively. It is re-
ported that BZD promotes the proliferation of bone
marrow cells of anemic mice, and that addition of
BZD to the media in cultures of spleen cells, macro-
phages, lung and skeletal muscle resulted in strong
stimulation of hematopoietic cells.14 Previous studies
of SWD have shown that it affected the expression
of apoptosis proteins, proliferation and differentiation
of hematopoietic progenitor stem cells,15 ameliorated
bone marrow damage after radiation.16 It has been
proposed as an effective, nontoxic, orally adminis-
tered agent for cancer chemoprevention via activation
of the nuclear factor-erythroid 2-related factor-2
(Nrf2) pathway.17 Combined chemotherapy with
SJZD plus low-dose mitomycin C significantly inhib-
ited tumor growth in mice with bladder carcinoma,
while attenuating toxicity attenuation and increasing
efficacy.18 A comparison of the radioprotection con-
ferred by SWD and SJZD found that SJZD and its
ingredients were not as effective as SWD.19 The three
decoctions are closely linked by TCM pharmacology,
but comparative studies of the three formulae have
not been conducted.
The aim of this study was to compare the anti-anemia
effects of BZD, SWD and SJZD in mice with 5-FU-in-
duced anemia and to investigate the hematopoietic
mechanisms of these three TCM preparations. It is
hoped that this preliminary laboratory data will sup-
port the scientific rationale for further clinical applica-
tions, reflect the modern Qi and blood concept in Chi-
nese medicine.
Table 2 Effects of the three decoctions on hematologic parameters determined on day 15 ( xˉ ± s)
Group
Normal
Model
BZD
SWD
SJZD
RBC
(×1012/L)
8.597±0.324a
5.438±0.244b
6.986±0.728a
6.897±0.623a
6.02±0.422b
HGB
(g/L)
131.833±5.981a
83.5±9.731b
106.333±8.981a
109.6±8.620a
90.857±7.081b
WBC
(×109 /L)
6.698±1.014a
2.91±0.438b
4.03±0.560a
3.9±0.328c
3.6±0.556d
HCT (%)
44.667±1.954a
28.683±3.544b
35.333±3.075c
33.6±4.665d
28.083±2.803b
RC (%)
0.673±0.055a
0.093±0.029b
0.277±0.042a
0.148±0.034c
0.126±0.035b
Notes: mice in the SWD, SJZD and BZD groups were given the decoctions by intragastric administration at a daily dose of 0.2 mL/10 g
body weight for 10 days. Mice in the Normal and Model groups were given an equal volume of normal saline. Mice were sacrificed on day
15 and femur was aseptically removed for cell cycle analysis. After administrated with three decotions for 10 days (0.2 mL/10 g body
weight), about 100 μL of retro-orbital sinus blood was collected using EDTA-coated capillary tubes. RBC, HGB, WBC, HCT and RC
were measured. BZD: Bazhen decoction; SWD: Siwu decoction; SJZD: Sijunzi decoction; RBC: red blood cell; HGB: hemoglobin; WBC:
white blood cell; HCT: hematocrit; RC: reticulocyte. aP < 0.001, cP < 0.01, dP < 0.05 vs Model group; bP < 0.001 vs Normal group.
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MATERIALS ANDMETHODS
Materials
The Traditional Chinese Medicines were supplied by
the Traditional Chinese Medicine hospital in Beibei,
Chongqing, China. Their Chinese names, Latin
names, Plant scientific name and dose (g) used in three
decoctions were presented in Table 1. BZD, SWD, and
SJZD were crushed into small pieces, suspended in 1 L
distilled water and washed twice for 30 min. The mix-
tures were filtered, and the filtrates were combined and
concentrated to 2.0 g/mL using a routine method. The
decoctions were stored at 4℃ until used.
5-Fluorouracil (250 mg/10 mL) was obtained from Jin-
yao Amino Acid Co., Ltd. (Tianjin, China). All en-
zyme-linked immuno sorbent assay (ELISA) kits were
purchased from Dingguo Changsheng Biotech Co.,
Ltd. (Beijing, China). TRIpure reagent was obtained
from Roche Pharmaceuticals Ltd. (Shanghai, China).
M-Mulv Reverse Transcriptase Kits were supplied by
Promega Biological Technology Co., Ltd. (Beijing, Chi-
na). Taq polymerase and DNaseI (RNase free) were
purchased from TaKaRa Biotechnology Co., Ltd. (Da-
lian, China). PCR primers were synthetized by West-
ern Biotechnology, Inc. (Chongqing, China). All other
reagents were of analytical grade.
Animals and experimental protocols
A total of 80 female Kunming mice, weighing (27 ±
2) g and 12 weeks of age, were supplied by the Labora-
tory Animal Center of Chongqing Medical University,
Chongqing, China (Certificate of Conformity: 2002A
040). All animal studies were performed in accordance
with the International Guiding Principles for Biomedi-
cal Research Involving Animals (1985) developed by
the Council for International Organizations of Medical
Sciences and relevant institutional guidelines. Mice
were maintained in standard polypropylene transparent
cages in a 12 h light/dark cycle and had free access to
water and food. The study was approved by the experi-
mental animal ethics committee of Southwest Universi-
ty of Traditional Chinese Medicine.
After a 1 week acclimatization period, the 80 mice
were randomly divided into five groups of 16 mice
each using a table of random numbers. These were a
normal group (Normal), an anemia model group
(Model), and anemia groups treated with Bazhen de-
coction (BZD), Siwu decoction (SWD) or Sijunzi de-
coction (SJZD). The observation period was from day
0 to day 15. There was no significant between-group
differences in the peripheral hemogram on day 0.5-FU
at a dose of 150 mg/kg was intravenously administered
to the four groups of anemic mice on day 5. Mice in
the SWD, SJZD and BZD groups were given the de-
coctions by intragastric administration at a daily dose
of 0.2 mL/10 g body weight for 10 days. Mice in the
Normal and Model groups were given an equal volume
of normal saline. Blood cell counts were obtained in all
five groups on days 5, 10, and 15. All mice were sacri-
ficed on day 15, and blood samples were collected for
cytokine analysis. Bone marrow cells were harvested
from both femurs for cell morphology and bone mar-
row cell-cycle assays. Kidney and liver tissues were
stored in liquid nitrogen for subsequent quantitative re-
al-time polymerase chain reaction (qRT-PCR) assay.
Hematology analysis
Peripheral blood was drawn from the retro-orbital ve-
nous plexus on days 5, 10, 15 and collected in tubes
containing EDTA. The red blood cells (RBCs), hemo-
globin (HGB), hematocrit (HCT), white blood cells
(WBCs), and reticulocytes (RCs) in each sample were
determined using an automatic analyzer.
Bone marrow cell morphology and cell cycle analysis
Mice were sacrificed on day 15 and both femurs were
aseptically removed for assay of bone marrow cellular
morphology and cell cycle analysis. Bone marrow ob-
tained from the femurs was stained by the Wright-Gi-
emsa method for the morphological analysis, and the
number of nucleated bone marrow cells was deter-
mined at high magnification (´400).20,21 For cell cycle
analysis, bone marrow was carefully pipetted up and
down in phosphate-buffered saline (PBS) until the cells
had dispersed, forming a single cell suspension. The su-
pernatant was discarded following centrifugation for 5
min at 1000 rpm at 4 ℃. The precipitates were washed
twice with PBS, fixed with 70% ethanol at 4 ℃ ,
washed twice with PBS, incubated with 10 mg/L
RNAse and 1 mL 50 mg/L propidium iodide at 4 ℃
for 30 min in the dark. The cell cycle assay was by flow
cytometry,22,23 and the proliferation index (PI) was cal-
culated as (S+G2/M)/(G0/G1+S+G2/M) ´100%.
Cytokine assay
Sera obtained from blood samples collected from the
retro-orbital venous plexus on day 15 were in the cyto-
kine assays. The concentrations of interferon-γ
(IFN-γ), interleukin-3 (IL-3), erythropoietin (EPO),
granulocyte-macrophage colony stimulating factor
(GM-CSF) and tumor necrosis factor-α (TNF-α) in
the serum were measured by enzyme-linked immuno-
sorbent assay (ELISA).
qRT-PCR assay of EPO transcription in kidney and
liver tissue
On day 15, the kidneys and liver were removed in an
RNAse-free environment and stored in liquid nitrogen
until assayed for the expression of EPO mRNA by
qRT-PCR technology. The sequences of the EPO prim-
ers were: upstream, 5′-GAGGCAGAAAATGTCAC-
GATG-3′ ; downstream: 5′-CTTCCACCTCCATTC-
TTTTCC-3′ , and the PCR product size was 112 bp.
The β-actin primers were: upstream, 5′-ATGGAT-
GACGATATCGCT-3′ ; downstream 5′-ATGAGG-
TAGTCTGTCAGGT -3′ , and the PCR product size
was 569 bp.
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Total RNA was extracted from tissues using TRIpure
reagent following the manufacturer's protocol, and 5
μL of each total RNA sample was reverse transcribed
into cDNA using 1 μL of M-Mulv reverse transcrip-
tase. PCR was performed using 2 μL of template cD-
NA, 1 μL forward primer and 1 μL reverse primer,
0.5μL Taq polymerase, and 1 μL of dNTP mix. PCR
amplification was carried out using a protocol with an
initial denaturing step at 94 ℃ for 4 min, followed by
35 cycles of 94 ℃ for 20 s, 60 ℃ for 30 s, and 72 ℃
for 30 s. After amplification, 8 μL of each PCR prod-
uct was fractionated on a 1% agarose gel and visualized
by ethidium bromide staining. β-actin was used as in-
ternal control. The band intensity of ethidium bro-
mide fluorescence was measured using Quantity One
v4.62 gel analysis software from BioRad (Hercules,
CA, USA). The expression of target genes was present-
ed as the ratio of target to the β-actin control fluores-
cence intensity.
Statistical analysis
The results were expressed as means ± standard devia-
tion ( xˉ ± s) and analyzed by SPSS v.20.0 statistical
software (IBM, Chicago, IL, USA). Statistical signifi-
cance was determined by one-way analysis of variance
followed by the least significant difference-t test. P val-
ues < 0.05 and < 0.01 were considered significant and
extremely significant, respectively.
RESULTS
Effects of the three prescriptions on the peripheral
hemogram
As shown in Table 2, RBC, HGB, HCT, WBC and
RC values were significantly lower in the Model group
than in the Normal group. BZD and SWD treatment
significantly increased RBC count, HGB concentra-
tion (P < 0.001), WBC count (P < 0.001 and P < 0.01
respectively), HCT (P < 0.01 and P < 0.05 respective-
ly), and RC count (P < 0.001 and P < 0.01) compared
with the Model group. The RC count on day 15 sug-
gested that BZD-treated mice might have a hematopoi-
esis activity similar to that of normal mice, but the RC
counts of BZD-treated mice did not reach a normal
level. The RBC counts and HGB concentrations in
each group (Figure 1) indicate that both BZD and
SWD had a significant therapeutic effect in anemic
mice, and that BZD achieved better therapeutic ef-
fects than SWD. However, SJZD increased only the
levels of WBC (P < 0.05), and was not shown to signif-
icantly promote hematopoiesis in the anemic mice.
Effects of the three prescriptions on the proliferation
of bone marrow cells
The numbers of nucleated bone marrow cells in each
Table 1 Compositions and dose of three decoctions
Chinese name
Danggui
Shudi
Baishao
Chuanxiong
Fuling
Gancao
Baizhu
Dangshen
Latin name
Radix Angelicae Sinensis
Radix Rehmannia Libosch
Radix Paeoniae Alba
Rhizoma Chuanxiong
Poria Cocos
Radix Glycyrrhiza
Rhizoma Atractylodis Macrocephalae
Radix Codonopsis
Plant scientific name
Angelica sinensis (Oliv.) Diels
Rehmannia glutinosa (Gaertn.) DC.
Paeonia sterniana H.R.Fletcher
Ligusticum striatum DC.
Poria cocos wolf
Glycyrrhiza uralensis Fisch.
Atractylodes macrocephala Koidz
Codonopsis pilosula (Franch.) Nannf.
BZD
dose (g)
10
15
8
5
8
5
10
3
SWD
dose (g)
20
30
20
12
-
-
-
-
SJZD
dose (g)
-
-
-
-
9
6
9
10
0 5 10 15 20
Time after 5-Fu (Days)
Normal Model BZD SWD SJZD
180
160
140
120
100
80
60
40
20
0
a
aa
a
RB
C
(×1
0Λ
12
/L)
12
10
8
6
4
2
0
0 5 10 15 20
Time after 5-Fu (Days)Normal Model BZD SWD SJZD
a a
aab
RB
C
(×1
0Λ
12
/L)
A
B
Figure 1 Effects of the three decoctions on RBC and HGB in
each group on days 0, 5, 10, 15
A: RBC; B: HGB. Mice in the SWD, SJZD and BZD groups were
given the decoctions by intragastric administration at a dai-
ly dose of 0.2 mL/10 g body weight for 10 days. Mice in the
Normal and Model groups were given an equal volume of
normal saline. Mice were sacrificed on day 15 and femur
was aseptically removed for cell cycle analysis. BZD: Bazhen
decoction; SWD: Siwu decoction; SJZD: Sijunzi decoction;
RBC: red blood cell; HGB: hemoglobin. aP < 0.001, bP < 0.01
vsModel group.
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smear were counted at high magnification (× 400). As
shown in Figure 2, myeloproliferative capacity was
greatly suppressed in the Model group (P < 0.001 vs
Normal), while the numbers of nucleated cells in the
BZD and SWD groups indicated active bone marrow
hyperplasia (both P < 0.001 vs Model). The results
showed that BZD and SWD treatment promoted the
recovery of myeloproliferative ability in anemic mice,
however, SJZD did not have a significant effect on
bone marrow hyperplasia (P < 0.001 vs Normal).
Effects of the three prescriptions on bone marrow cell
cycle
Flow cytometry was used to assay bone marrow sam-
ples harvested on day 15. The effects on the bone mar-
row cell cycle in each experimental group are shown in
Figure 3 and Table 2. The proportion of bone marrow
cells in myelosuppressed mice that were in G0/G1
phase arrest was significantly greater than in mice in
the Normal group (P < 0.05), and few cells were in the
G2/M phase (P < 0.001 vs Normal). Compared with
the Model group, both BZD and SWD decreased the
proportion of cells in G0/G1 (P < 0.01) and increased
the proportion of cells in G2/M (P < 0.001 and P <
0.01 respectively) in the myelosuppressed mice, signifi-
cantly promoting the entry of bone marrow cell into
the cell cycle. BZD, SWD and SJZD treatment effec-
tively improved the recovery of hemopoiesis in anemic
mice by promoting the entry of bone marrow cells
from G0/G1 phase arrest into the cell cycle and acceler-
ating G1-S phase and SG2-/M phase transitions.
Effects of the three prescriptions on serum cytokine
expression
The EPO, IL-3, and IFN-γ concentrations observed
on day 15 are shown in Figure 4. Compared with the
Normal group, the administration of 5-FU significant-
ly decreased the expression of EPO (P < 0.001) and
IL-3 (P < 0.001), and significantly elevated the IFN-γ
concentration (P < 0.01). Oral administration of BZD
for 10 days markedly increased the concentrations of
EPO (P < 0.001) and IL-3 (P < 0.05) and significantly
decreased IFN-γ (P < 0.001) concentrations versus the
Model group. The effects of SWD on IL-3 and IFN-γ
level were similar to BZD, while there was no signifi-
cant difference in EPO concentration compared with
the Model group. EPO, IL-3 and IFN-γ expression
was not influenced by SJZD. In addition, the three pre-
scriptions did not have significant effects on the serum
concentration of GM-CSF and TNF-α in the Model
and treatment groups. The detailed data of the effects
of treatment on GM-CSF and TNF-α are not shown.
Effects of the three prescriptions on transcription of
EPO in kidney and liver tissue
Based on the finding that BZD affected the EPO con-
centration in serum, we assumed that it was able to
promote the transcription of EPO. To confirm this, we
assayed the expression of EPO mRNAs in kidney and
liver tissue by qRT-PCR. Ten days after the injection of
5-FU, EPO mRNA expression had significantly de-
creased in liver (P < 0.05) and kidney (P < 0.001) tis-
sue of mice in the Model group. As shown in Figures 5
and 6, BZD significantly increased the expression of
EPO mRNA in the kidney and liver of the mice (both
P < 0.01); SWD only up-regulated the expression of
EPO mRNA only in kidney tissue (P < 0.01). Howev-
er, SJZD did not increase EPO mRNA expression of
the transcripts.
DISCUSSION
Based on the TCM theory of 'Qi and blood', SWD,
SJZD and BZD, have been used to treat blood defi-
ciency, Qi deficiency, and Qi-and-blood deficiency for
more than 500 years even though their mechanisms of
action have not been determined. Herein, we estab-
lished a mouse model of blood deficiency induced by
5-FU, following methods used to induce anemia,24 to
investigate possible mechanisms using a modern bio-
medical approach.
The pharmacological action of 5-FU includes the im-
pairment of DNA synthesis through the inhibition of
thymidylate synthetase activity. Therefore, 5-FU is par-
ticularly toxic to actively proliferation tissues such as
bone marrow, which is the "factory" where all blood
cells are produced.25 The intravenous administration of
5-FU led to a dramatic decrease in RBC, WBC, and
RC counts, HGB concentration, and HCT in the mice
during the 10 day observation period. The changes in
these routine blood indexes demonstrated that the he-
mopoiesis was inhibited or impaired, resulting in se-
vere cytopenia. Consistent with the peripheral blood
Normal Model BZD SWD SJZD
120
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20
0
BM
NC
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P
Groups
a
a
Figure 2 Number of nucleated bone marrow cells on day 15
Mice in the SWD, SJZD and BZD groups were given the de-
coctions by intragastric administration at a daily dose of 0.2
mL/10 g body weight for 10 days. Mice in the Normal and
Model groups were given an equal volume of normal saline.
Mice were sacrificed on day 15 and femur was aseptically re-
moved for cell cycle analysis. Bone marrow obtained from
the femurs was stained by the Wright-Giemsa method for
the morphological analysis, and the number of nucleated
bone marrow cells was determined at high magnification ×
400). BZD: Bazhen decoction; SWD: Siwu decoction; SJZD: Si-
junzi decoction; BMNC/HP: nucleated bone marrow cells/
high magnification. aP < 0.001.
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Figure 3 Effects of the three decoctions on the bone marrow cell cycle on day 15
A: normal group; B: model group; C: BZD group; D: SWD group; E: SJZD group. Mice in the SWD, SJZD and BZD groups were given
the decoctions by intragastric administration at a daily dose of 0.2 mL/10 g body weight for 10 days. Mice in the Normal and Mod-
el groups were given an equal volume of normal saline. Mice were sacrificed on day 15 and femur was aseptically removed for cell
cycle analysis. Bone marrow cells were stained with propidium iodide and analyzed by flow cytometry. BZD: Bazhen decoction;
SWD: Siwu decoction; SJZD: Sijunzi decoction.
BA
C D
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Table 3 Percentage of bone marrow cells in different cell cycle phases ( xˉ ± s)
Group
Normal
Model
BZD
SWD
SJZD
G0/G1 (%)
54.4±8.8a
69.3±9.1b
51.9±6.6c
52.5±8.3c
58.7±9.9
S (%)
30.6±5.0
27.2±3.2
32.4±5.6
38.6±6.5c
29.3±3.1
G2/ M (%)
15.0±4.3d
3.5±1.2e
15.7±2.5d
8.9±2.6c
12.0±3.6d
PI
45.6±9.2c
30.7±5.9f
48.1±6.6c
47.5±8.3c
41.3±7.7a
Notes: mice in the SWD, SJZD and BZD groups were given the decoctions by intragastric administration at a daily dose of 0.2 mL/10 g
body weight for 10 days. Mice in the Normal and Model groups were given an equal volume of normal saline. Mice were sacrificed on day
15 and femur was aseptically removed for cell cycle analysis. Bone marrow cells in five groups were removed on day 15 after 10 days of
treatment. Data are expressed as xˉ ± s (n = 8). BZD: Bazhen decoction; SWD: Siwu decoction; SJZD: Sijunzi decoction; PI: proliferation-
index. aP < 0.05, cP < 0.01, dP < 0.001 vs model group; bP < 0.05, eP < 0.001, fP < 0.01 vs normal group.
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Figure 6 Effects of the three prescriptions on erythropoietin transcripts in liver and kidney
A: liver; B: kidney. Mice in the BZD, SWD, and SJZD groups were given the decoctions by intragastric administration at a daily dose
of 0.2 mL/10 g body weight for 10 days. Mice in the Normal and Model groups were given an equal volume of normal saline. Mice
were sacrificed on day 15 and femur was aseptically removed for cell cycle analysis. On day 15, the kidneys and liver were re-
moved in an RNAse-free environment and assayed for the expression of EPO mRNA by qRT-PCR technology. The intensities of
bands were normalized against β-actin intensity. BZD: Bazhen decoction; SWD: Siwu decoction; SJZD: Sijunzi decoction. aP <
0.05, bP < 0.01, cP < 0.001 vsModel group.
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Figure 4 Effects of the three decoctions on serum cytokines EPO, IL-3
and IFN-γ on day 15
A: EPO, B: IL-3, C: IFN-γ. Mice in the SWD, SJZD and BZD groups were
given the decoctions by intragastric administration at a daily dose of
0.2 mL/10 g body weight for 10 days. Mice in the Normal and Model
groups were given an equal volume of normal saline. Mice were sacri-
ficed on day 15 and femur was aseptically removed for cell cycle analy-
sis. Sera obtained from blood samples collected from the retro-orbital
venous plexus on day 15 were in the cytokine assays. Their concentra-
tions in the serum were measured by enzyme-linked immunosorbent
assay. BZD: Bazhen decoction; SWD: Siwu decoction; SJZD: Sijunzi de-
coction; EPO: erythropoietin; IL-3: interleukin-3; IFN-γ: ininterferon-γ.
aP < 0.001, bP < 0.05, cP < 0.01 vsModel group.
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Figure 5 Effects of the three decoctions on erythropoietin transcripts in liver and kidney
A: liver; B: kidney. 1: Normal group; 2: Model group; 3: BZD group; 4: SWD group; 5: SJZD group. Mice in the BZD, SWD, and SJZD
groups were given the decoctions by intragastric administration at a daily dose of 0.2 mL/10 g body weight for 10 days. Mice in
the Normal and Model groups were given an equal volume of normal saline. BZD: Bazhen decoction; SWD: Siwu decoction; SJZD:
Sijunzi decoction. On day 15, the kidneys and liver were removed in an RNAse-free environment and assayed for the expression
of EPOmRNA by qRT-PCR technology. The intensities of bands were normalized against β-actin intensity.
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data, injection of 5-FU reduced the cellular compo-
nents of bone marrow and greatly reduced the myelo-
proliferative capacity of the mice. Evaluation of bone
marrow smears confirmed that the number of nucleat-
ed cells in the Model group mice was significantly low-
er than that in Normal mice, which suggests depressed
bone marrow proliferation. These observations con-
firmed that we successfully established a mouse anemia
model. Oral administration of BZD and SWD was fol-
lowed by remarkably improvement of RBC, WBC,
and RC counts, HGB concentration, and HCT. At the
same time, increase in the number of nucleated cells in
the bone marrow of mice given BZD and SWD dem-
onstrated active bone marrow hyperplasia. BZD was
the most effective of the three decoctions in promoting
the recovery or the enhancement of hemopoiesis.
The cell cycle distribution of bone marrow cells is an
important indicator for evaluating hematopoietic sys-
tem function and reflects the status of bone marrow
cell proliferation. Most hematopoietic stem cells
(HSCs), which originate in the bone marrow, are in G0
and temporarily or permanently out of the cell cycle. A
minority are in the proliferative state.26 Hemopoiesis is
sensitive to chemotherapeutic agents such as 5-FU,
which usually damage the bone marrow and affect nor-
mal hematopoiesis, changing the proportions of cells
in different phases of cell cycle. The DNA damage
caused by chemotherapy prevents entry into the cell cy-
cle and causes cell cycle arrest.27 Releasing bone mar-
row cells from G1 phase (first gap phase) arrest, promot-
ing S-phase (DNA synthesis phase) entry, and progres-
sion to the G2 (second gap phase)/M (mitosis phase)
phase are the important mechanisms to overcome the
myelosuppression caused by chemotherapy drugs. The
flow cytometry assay revealed that nearly 70% of the
mouse bone marrow cells were arrested in G0 phase
and had not entered into division and proliferation af-
ter injection of 5-FU. It was noted that all three pre-
scriptions promoted recovery from myelosuppression
by accelerating the G0/G1-S phase and S-G2/M phase
transitions and increased the PI of bone marrow cells.
The findings indicated that BZD, SWD, and SJZD all
stimulated bone marrow nucleated cells to enter the
cell cycle and promoted the proliferation and differenti-
ation of hematopoietic progenitor cells. However,
SJZD did not promote the recovery of hematopoiesis
in the bone marrow even though it promoted entry to
the cell cycle, possibly owing to being unable to in-
crease cytokine production. We conclude that BZD
and SWD played vital roles in enhancing the prolifera-
tion of myeloid progenitors, thus having an anti-ane-
mia effect via hematopoietic lineage development.
Hematopoietic progenitor cells (HPCs), especially ear-
ly HPCs with high proliferation potential, may not all
be cycling (i.e., actively proliferating). HSCs and
HPCs in G0 phase partly depend on the regulation of
hematopoietic cytokines to enter the cell cycle. Thus,
we assayed the effects of the three prescriptions on
some cytokines that are thought to either suppress or
stimulate immature erythroid cells.28 EPO, IL-3, and
IFN-γ, have been reported to influence erythropoie-
sis.28 IL-3, a multipotent hematopoietic growth factor,
plays a significant role in the regulation of hematopoi-
etic function and immunology in vivo.29 EPO is an es-
sential factor for the viability and proliferation of eryth-
rocytic progenitors30 and for the production of red
blood cells.31 IFN-γ, an erythroid cell suppressing cyto-
kine in the bone marrow, can cause the early death of
erythroid progenitor cells, thereby antagonizing the an-
ti-apoptotic action of EPO.32-34 5-FU injection resulted
in a significant decrease in EPO and IL-3 concentra-
tions and an increase in IFN-γ concentration. SJZD
did not improve abnormal cytokine secretion, but
BZD and SWD contributed to improvement. BZD
and SWD promoted erythropoiesis, possibly by inhibit-
ing the secretion of IFN-γ and promoting the release
of EPO and IL-3, which would be expected to improve
the proliferation and differentiation of immature ery-
throid cells. These results suggest that BZD and SWD
enhanced the production of hematopoietic factors and
the proliferation of hematopoietic progenitor cells. The
recovery of mice from 5-FU-induced anemia, indicates
that BZD and SWD enhanced cytokine production by
lymphocytes.
EPO is a glycoprotein hormone that regulates the pro-
duction of red blood cells. It is primarily synthesized in
the kidney and secreted by renal cortical interstitial
cells in response to tissue hypoxia. A small amount of
extra-renal EPO is produced by the liver. Recombinant
human EPO has been widely used to treat anemia
caused by chronic renal failure.28 In our experimental
model, BZD greatly upregulated EPO mRNA expres-
sion in the liver and kidneys of myelosuppressed mice.
BZD also promoted the synthesis and secretion of
EPO and the formation of RBCs. Even though SWD
significantly increased the expression of EPO mRNA
in the kidney, the concentration of EPO in the serum
of SWD-treated mice was lower than that observed in
the Normal group. We thus infer that BZD could af-
fect more factors related to the secretion and synthesis
of EPO than SWD.
Our experimental results demonstrate establishment of
a blood deficiency model that was useful in studying
"Qi and blood theory", an important component of
TCM.35 Qi is the Yang, whereas blood constitutes the
Yin aspects of the body.3 In brief, it is believed that Qi
is the commander of blood, and blood is the mother of
Qi. When humans or animals are in a state of blood de-
ficiency, the lack of blood would lead loss of Qi carrier
and subsequent worsening of blood deficiency. With in-
sufficient Qi, the organs cannot produce, move, or con-
trol the blood, ultimately resulting in Qi and blood de-
ficiency.3 In TCM, syndrome differentiation treatment,
or "treating deficiency with tonification" treats blood
deficiency with blood-supplementing formulas. SWD,
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a representative prescription of a blood-supplementing
formula, and BZD, which enriches both blood and Qi,
had significant therapeutic effects on 5-FU-induced
anemia in our mouse model. Associated with "Qi and
blood theory", promoting Qi could contribute blood
production and relieve blood stagnation. Moreover, en-
riching blood could bring adequate Qi to the organs.
SJZD could strengthen only the spleen and replenish
Qi, which was used for Qi deficiency and not blood de-
ficiency. SJZD could theoretically promote hematopoi-
esis because it enhanced Qi, while lack of blood in the
mice led to the loss of carrier (blood is the mother of
Qi), which implies that there was no significant differ-
ence between SJZD group and Model group in our
study. The study results are consistent with the "Qi and
blood theory" of TCM and provide preliminary labora-
tory data for eventual clinical applications.
In conclusion, both the Bazhen and Siwu decoctions
had therapeutic effects on blood deficiency as well as
anemia. The assay results indicated that BZD and
SWD ameliorated the bone marrow toxicity induced
by 5-FU, and improved hematopoiesis by improving
cytokine expression. It is noteworthy that BZD and
SWD inhibited the secretion of IFN-γ and promoted
the release of IL-3, and activated the expression of
EPO mRNA, especially in the kidney. Our observa-
tions indicate that BZD and SWD are potential thera-
peutic drugs for anemia induced by chemotherapeutic
agents like 5-FU. The results support further research
on the effectiveness of pro-hematopoietic monomers in
these TCM prescriptions and on their biological targets
to provide additional evidences for the international
use of TCM.
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